[{"Assets_0_Q3_USD":772496000.0,"CommonStockSharesOutstanding_0_Q3_shares":88462002.0,"NetIncomeLoss_1_Q3_USD":-11125000.0,"NetIncomeLoss_3_Q3_USD":-149436000.0,"StockholdersEquity_0_Q3_USD":347512000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171101"}]